Abstracts Archive - Page 796 of 1683 - ATC Abstracts

2018 American Transplant Congress
SGLT2 Inhibition in Kidney Transplant Recipients with Diabetes
M. Guthoff,¹ M. Mahling,¹ S. Nadalin,² N. Heyne.¹
¹Dept. of Endocrinology and Diabetology, Angiology, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany; ²Dept. of General, Visceral and Transplant Surgery, University of Tübingen, Tübingen, Germany.
Purpose: Sodium-glucose cotransporter 2 (SGLT2) inhibition has been shown to reduce cardiovascular mortality and preserve kidney function in patients with type 2 diabetes. Kidney transplant…
2018 American Transplant Congress
Utility of Preoperative CT to Guide Perioperative Management for Kidney Transplantation
E. Werlin,¹ J. Walker,² J. Freise,¹ P. Stock,¹ J. Hiramoto.²
¹Department of Transplant Surgery, UCSF, San Francisco, CA; ²Department of Vascular and Endovascular Surgery, UCSF, San Francisco, CA.
Background: CT scans of the abdomen and pelvis (CT A/P) are performed for pre-transplant (tx) evaluation in patients (pts) at high risk for post-operative cardiovascular…
2018 American Transplant Congress
Impact of Balanced Solutions on Acid Base Disorders during and after Kidney Transplantation
N. Maillard,² H. Chraka,¹ G. Claisse,² E. Alamartine,² S. Molliex,¹ C. Mariat.²
¹Département d'Anesthésie Réanimation, CHU Saint Etienne, Saint Etienne, France; ²Service de Néphrologie Dialyse Transplantation Rénale, CHU Saint Etienne, Saint Etienne, France.
Fluid management of peri operative period of kidney transplantation is crucial to drive volemia, acid/base and electrolyte balance, as renal function is usually absent or…
2018 American Transplant Congress
Donor TM6SF2 rs58542926 Genotype is a Risk Factor for Liver Graft Steatosis
I. Mikova,¹ M. Neroldova,² J. Hubacek,² D. Dlouha,² L. Kolesar,³ M. Jirsa,² E. Honsova,⁴ E. Sticova,⁴ V. Lanska,⁵ J. Spicak,¹ P. Trunecka.¹
¹Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; ²Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; ³Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; ⁴Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; ⁵Medical Statistics Unit, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Background & Aims: The rs58542926 c.449C>T (p.E167K) polymorphism in TM6SF2 (transmembrane 6 superfamily member 2) is one of genetic factors predisposing to nonalcoholic fatty liver…
2018 American Transplant Congress
Liver Retransplantation and Renal Failure: The Benefit of Simultaneous Kidney Transplant
J. Berumen,¹ V. Irine,² S. Mita,² S. Gabriel,¹ M. Kristin.¹
¹Department of Surgery, University of California San Diego, San Diego, CA; ²Department of Medicine, University of California San Diego, San Diego, CA.
Liver retransplantation has poor survival compared to primary liver transplant. Renal failure is a proven negative risk factor for survival with retransplant. Our aim was…
2018 American Transplant Congress
ADL and IADL Limitations Resolve but New Cognitive Impairments Develop in Liver Transplant Recipients
J. Corriveau, R. Chandrasekhar, S. Geevarghese.
Vanderbilt University School of Medicine, Nashville.
Introduction: Survivors of critical illness often have prolonged cognitive and functional impairments, and suffer from depression and PTSD. This constellation of symptoms is termed post-intensive…
2018 American Transplant Congress
Sufficient Hepatic Artery Flow Redeems Poor Portal Vein Flow after Liver Transplantation in Patients with Porta Vein Thrombosis
L. Coromina Hernandez, K. Sasaki, D. Firl, J. McVey, M. Fujiki, F. Aucejo, B. Eghtesad, C. Quintini, C. Miller, K. Hashimoto.
General Surgery, Cleveland Clinic, Cleveland, OH.
Objective:Although portal vein thrombosis(PVT) in liver transplantation is no longer a contraindication, it remains technically challenging. Insufficient intraoperative PV flow after PV thrombectomy/reconstruction was reported…
2018 American Transplant Congress
Increased BMI is a Predictor of Early Post-Transplant Cardiac Events and Mortality
A. Mahgoub, S. Jackson, J. Lake, N. Lim.
Medicine, University of Minnesota, Minneapolis, MN; Transplant Information Services/ISR2, Fairview Health Services, Minneapolis, MN.
Background: Cardiac events (CVE) remain a significant source of morbidity in the early post-transplant(post-tx) period despite extensive evaluation prior to liver transplant(LT). It is important…
2018 American Transplant Congress
Portal Vein Thrombosis (PVT) in Liver Transplantation – Recent Experience
D. Bruce, H. Bohorquez, J. Seal, A. Cohen, E. Bugeaud, I. Carmody, D. Sonnier, A. Mathur, L. De Gregorio, H. Sharma, G. Loss.
Ochsner Multi-Organ Transplant Institute, Ochsner Medical Center, New Orleans, LA.
From 01-Nov-2012 to 31-Oct-2017, 1025 liver transplants were done at our center. Excluding retransplants and combined liver-kidney transplants, 830 transplants were studied for this abstract…
2018 American Transplant Congress
Lactate/platelet Ratio after Liver Transplantation; a Novel Predictor for Short-Term Graft Failure
K. Takahashi,¹ S. Nagai,² M. Safwan,² K. Collins,² M. Rizzari,² A. Yoshida,² N. Ohkohchi,¹ M. Abouljoud.²
¹Surgery, University of Tsukuba, Tsukuba, Ibaraki, Japan; ²Transplant, Henry Ford Hospital, Detroit, MI.
Background; Recently, platelet count and lactate level after liver transplantation (LT) have been both separately reported as predictors of graft failure. In this study, we…